278 related articles for article (PubMed ID: 36826096)
21. [Splenic marginal zone B-cell lymphoma with epidermotropic skin involvement].
Gómez-de la Fuente E; Villalón LB; Calzado-Villarreal L; Pinedo-Moraleda F; López-Estebaranz JL
Actas Dermosifiliogr; 2012 Jun; 103(5):427-31. PubMed ID: 21885023
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
Moore EM; Swerdlow SH; Gibson SE
Am J Surg Pathol; 2018 Mar; 42(3):342-350. PubMed ID: 29309299
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma.
Ikeda JI; Kohara M; Tsuruta Y; Nojima S; Tahara S; Ohshima K; Kurashige M; Wada N; Morii E
Hum Pathol; 2017 Jan; 59():70-79. PubMed ID: 27666766
[TBL] [Abstract][Full Text] [Related]
24. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients.
Berger F; Felman P; Thieblemont C; Pradier T; Baseggio L; Bryon PA; Salles G; Callet-Bauchu E; Coiffier B
Blood; 2000 Mar; 95(6):1950-6. PubMed ID: 10706860
[TBL] [Abstract][Full Text] [Related]
25. [Current management of marginal zone lymphomas].
Bonnet C; Lejeune M; Van Kemseke C; Bron D; Beguin Y
Rev Med Suisse; 2015 Aug; 11(483):1549-56. PubMed ID: 26502581
[TBL] [Abstract][Full Text] [Related]
26. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
[TBL] [Abstract][Full Text] [Related]
27. Primary spinal marginal zone lymphoma: case report and review of the literature.
Ahmadi SA; Frank S; Hänggi D; Eicker SO
Neurosurgery; 2012 Aug; 71(2):E495-508; discussion E508. PubMed ID: 22314752
[TBL] [Abstract][Full Text] [Related]
28. Follicular lymphoma and marginal zone lymphoma: how many diseases?
Laurent C; Cook JR; Yoshino T; Quintanilla-Martinez L; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):149-162. PubMed ID: 36394631
[TBL] [Abstract][Full Text] [Related]
29. Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells.
Novak U; Basso K; Pasqualucci L; Dalla-Favera R; Bhagat G
Br J Haematol; 2011 Nov; 155(3):362-5. PubMed ID: 21883140
[TBL] [Abstract][Full Text] [Related]
30. Nodal marginal zone lymphoma: Clinical features, diagnosis, management and treatment.
Tadmor T; Polliack A
Best Pract Res Clin Haematol; 2017; 30(1-2):92-98. PubMed ID: 28288722
[TBL] [Abstract][Full Text] [Related]
31. A roadmap for clinical trial design in marginal zone lymphoma.
Alderuccio JP; Habermann T; Kuker R; Moskowitz CH; Zelenetz AD; Lossos IS
Am J Hematol; 2022 Nov; 97(11):1398-1403. PubMed ID: 36030403
[TBL] [Abstract][Full Text] [Related]
32. Marginal Zone Lymphomas.
Bertoni F; Rossi D; Raderer M; Zucca E
Cancer J; 2020; 26(4):336-347. PubMed ID: 32732678
[TBL] [Abstract][Full Text] [Related]
33. Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study.
Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Kang HJ; Choi CW; Park J; Kim HJ; Kwon JH; Lee HS; Lee GW; Eom HS; Kwak JY; Suh C; Kim HJ
Cancer Sci; 2010 Nov; 101(11):2443-7. PubMed ID: 20831770
[TBL] [Abstract][Full Text] [Related]
34. Marginal zone lymphomas: management of nodal, splenic, and MALT NHL.
Kahl B; Yang D
Hematology Am Soc Hematol Educ Program; 2008; ():359-64. PubMed ID: 19074110
[TBL] [Abstract][Full Text] [Related]
35. Leukaemic subtype of marginal zone lymphoma: a presentation of three cases and literature review.
Tam CS; Prince HM; Westerman D; Seymour JF; Juneja S
Leuk Lymphoma; 2004 Apr; 45(4):705-10. PubMed ID: 15160943
[TBL] [Abstract][Full Text] [Related]
36. Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.
Conconi A; Raderer M; Franceschetti S; Devizzi L; Ferreri AJ; Magagnoli M; Arcaini L; Zinzani PL; Martinelli G; Vitolo U; Kiesewetter B; Porro E; Stathis A; Gaidano G; Cavalli F; Zucca E
Br J Haematol; 2014 Jul; 166(1):69-76. PubMed ID: 24673512
[TBL] [Abstract][Full Text] [Related]
37. Marginal zone lymphoma.
Shaye OS; Levine AM
J Natl Compr Canc Netw; 2006 Mar; 4(3):311-8. PubMed ID: 16507274
[TBL] [Abstract][Full Text] [Related]
38. Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites.
Kuper-Hommel MJ; van de Schans SA; Vreugdenhil G; van Krieken JH; Coebergh JW
Leuk Lymphoma; 2013 Sep; 54(9):1891-7. PubMed ID: 23302044
[TBL] [Abstract][Full Text] [Related]
39. State-of-the-art therapeutics: marginal-zone lymphoma.
Bertoni F; Zucca E
J Clin Oncol; 2005 Sep; 23(26):6415-20. PubMed ID: 16155028
[TBL] [Abstract][Full Text] [Related]
40. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma.
Hoffmann M; Kletter K; Becherer A; Jäger U; Chott A; Raderer M
Oncology; 2003; 64(4):336-40. PubMed ID: 12759529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]